Awapatent has a team of qualified patent attorneys who are specialists in protecting life science innovations. These experts have all the knowledge and experience required to give you sound, reliable advice on legal matters and the prosecution of patent applications in this complex field of technology.
We can help you with technical and legal matters in all fields of Life Sciences. We are well versed in how to prosecute patent applications worldwide and are often involved in conducting infringement and validity investigations for clients both on the European and the US market.
We also work with freedom-to-operate analyses as well as due diligence analyses for investment companies. In addition, our Life Sciences team has extensive experience in opposition and appeal proceedings before the European Patent Office (EPO). Several team members have also participated as technical experts in patent litigation in Swedish and Danish courts.
In addition, we offer international IP services in the fields of pharmaceuticals. Other examples include biopharmaceuticals, biological materials, drugs, stem cells, genetics, biochemistry, foodstuffs and biotechnology research tools.
Our Life Sciences team also has wide-ranging proficiency in DNA technology, including drafting applications for novel genes, proteins, recombinant proteins, vectors, transformed organisms, screening methods, etc.
For many years we have been drafting and handling applications relating to novel drugs, i.e. novel organic compounds, and novel medical uses of such drugs. Furthermore, the team members have extensive experience within the technical fields of immunology and microbiology, such as
micro-organisms. This area of technical expertise also includes functional foods, nutraceuticals and food supplements.
Our Life Sciences team has in-depth knowledge of how to prepare and prosecute SPC applications at the Swedish and Danish patent offices. Team members have also assisted in building up expertise in the procedures for SPCs for pharmaceuticals in Sweden and Denmark.